Synthesis of actinomycin and analogs. 12. Synthesis and some properties and antitumor effects of the actinomycin lactam analog, [di-(1'-L-.alpha.,.beta.-diaminopropionic acid)]actinomycin D

Journal of Medicinal Chemistry
1976.0

Abstract

A lactam analog of actinomycin D (AMD) has been synthesized as a potential antitumor chemotherapeutic agent. Both L-threonine residues were replaced by L-alpha,beta-diaminopropionic acid. Starting with Nalpha-benzyloxycarbonyl-Nbeta-tert-butyloxycarbonyl-L-alpha,beta-diaminopropionic acid methyl ester hydrochloride the linear intermediate Nalpha-benzyloxycarbonyl-Nbeta-(tert-butyloxycarbonylsarcosyl-L-N-methylvalyl)-L-alpha,beta-diaminopropionyl-D-valyl-L-proline p-nitrophenyl ester was prepared by conventional methods of peptide synthesis in solution. Selective cleavage of the Nbeta-tert-butyloxycarbonyl group and lactam formation afforded the desired cyclic pentapeptide derivative. The chromophore precursor, Nalpha-(2-nitro-3-benzyloxy-4-methylbenzoyl) substituent, was introduced via its symmetric anhydride. Catalytic reduction followed by ferricyanide-mediated phenoxazinone formation provided the lactam analog, [di(1'-L-alpha,beta-diaminopionic acid)]actinomycin D ([Dpr1]2-AMD). Its binding to natural and synthetic DNA and that of an analogous L-threo-alpha,beta-diaminobutyric acid containing lactam ([Dbu1]2-AMD) compared with the binding of AMD (in which the peptides are in lactone form) was studied by circular dichroic (CD) spectroscopy. The visible and uv CD spectra of free AMD differed from those of the free lactam analogs, indicating that the asymmetric environment of the pentapeptide rings in the region of the chromophore differs in free actinomycin lactone and lactams. In the presence of calf thymus DNA, PM2 DNA, and the synthetic d(A-T)-like copolymers containing 2,6-diaminopurine (DAP), poly[d(DAP-T)], and poly[d(DAP-A-T)], the rotational strengths of the optically active transitions in the visible region of the actinomycins increased, and the CD spectra in the presence of the various DNA duplexes were qualitatively similar. The CD spectra of bound actinomycin lactams resembled the spectrum of bound AMD. This suggests that the lactone and lactam actinomycins acquire a similar environment when bound to DNA. [Dpr1]2-AMD was less cytotoxic than AMD in antibacterial assays but exhibited somewhat higher toxicity in mice than AMD. At optimal dose levels the lactam analog had little or no antitumor activity in three murine tumor systems.

Knowledge Graph

Similar Paper

Synthesis of actinomycin and analogs. 12. Synthesis and some properties and antitumor effects of the actinomycin lactam analog, [di-(1'-L-.alpha.,.beta.-diaminopropionic acid)]actinomycin D
Journal of Medicinal Chemistry 1976.0
Synthesis and properties of some peptide analogs of actinomycin D
Journal of Medicinal Chemistry 1991.0
Synthesis and evaluation of bis-dipeptide and bis-tripeptide analogs of actinomycin D
Journal of Medicinal Chemistry 1978.0
Tetracyclic chromophoric analogs of actinomycin D: synthesis, structure elucidation and interconvertibility from one form to another, antitumor activity, and structure-activity relationships
Journal of Medicinal Chemistry 1983.0
Synthesis and biological properties of actinomycin D chromophoric analogs substituted at carbon 7 with aziridine and cyclopropyl functions
Journal of Medicinal Chemistry 1988.0
Synthesis and biological properties of actinomycin D chromophoric analogs substituted at the 7-carbon with aziridine and aminopropoxy functions
Journal of Medicinal Chemistry 1987.0
Carbon-7 substituted actinomycin D analogs as improved antitumor agents: synthesis and DNA-binding and biological properties
Journal of Medicinal Chemistry 1982.0
Synthesis and biological properties of N2-substituted spin-labeled analogs of actinomycin D
Journal of Medicinal Chemistry 1979.0
N2- and C-7-Substituted actinomycin D analogs: synthesis, DNA-binding affinity, and biochemical and biological properties. Structure-activity relationship
Journal of Medicinal Chemistry 1981.0
A phenazine analog of actinomycin D
Journal of Medicinal Chemistry 1979.0